Social prescribing for primary care in the UK: costs and health benefits are uncertain

Citation: Bickerdike L, Booth A, Wilson PM, et al. Social prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open 2017; 7: e013384 What is this? The COVID-19 pandemic is placing a strain on health systems and healthcare workers. Existing research on social prescri...

Descripción completa

Detalles Bibliográficos
Autor principal:	Allen, Claire
Formato:	Published Article
Publicado:	2020-04-23
Materias:	Coronavirus Infectious Diseases Health Personnel COVID-19
Acceso en línea:	https://www.evidenceaid.org/social-prescribing-for-primary-care-in-the-uk-costs-and-health-benefits-are-uncertain/ https://hdl.handle.net/20.500.12663/1212

id	PAO-20.500.12663-1212
record_format	dspace
spelling	Allen, Claire 2020-04-25T00:36:40Z 2020-04-25T00:36:40Z 2020-04-23 https://www.evidenceaid.org/social-prescribing-for-primary-care-in-the-uk-costs-and-health-benefits-are-uncertain/ https://hdl.handle.net/20.500.12663/1212 Citation: Bickerdike L, Booth A, Wilson PM, et al. Social prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open 2017; 7: e013384 What is this? The COVID-19 pandemic is placing a strain on health systems and healthcare workers. Existing research on social prescribing, which links patients in primary care to sources of support within the community, may provide information to ease this. In this systematic review, the authors searched for research evaluating any form of social prescribing programmes that had been conducted in the UK. They restricted the search to publications in English between 2000 and January 2016 and did the searches in February 2016. They included 1 randomised trial, 1 non-randomised trial, two qualitative studies, 4 uncontrolled before-and-after studies and 8 descriptive reports. What was found: Patient experience reports were generally positive about social prescribing in the UK, but the effects are not quantifiable. Although there may be a reduction in primary care and secondary care contacts, the extent of this, and the costs and health effects of social prescribing are uncertain. English Coronavirus Infectious Diseases Health Personnel COVID-19 Social prescribing for primary care in the UK: costs and health benefits are uncertain Evidence Aid Others Clinical characterization and management Published Article Protect Health Care Workers / Proteger la Salud de los Trabajadores
elec_str_mv	Organización Panamericana de la Salud
collection	Organización Panamericana de la Salud
title	Social prescribing for primary care in the UK: costs and health benefits are uncertain
spellingShingle	Social prescribing for primary care in the UK: costs and health benefits are uncertain Allen, Claire Coronavirus Infectious Diseases Health Personnel COVID-19
title_short	Social prescribing for primary care in the UK: costs and health benefits are uncertain
title_full	Social prescribing for primary care in the UK: costs and health benefits are uncertain
title_fullStr	Social prescribing for primary care in the UK: costs and health benefits are uncertain
title_full_unstemmed	Social prescribing for primary care in the UK: costs and health benefits are uncertain
title_sort	social prescribing for primary care in the uk: costs and health benefits are uncertain
author	Allen, Claire
author_facet	Allen, Claire
topic	Coronavirus Infectious Diseases Health Personnel COVID-19
topic_facet	Coronavirus Infectious Diseases Health Personnel COVID-19
publishDate	2020-04-23
format	Published Article
description	Citation: Bickerdike L, Booth A, Wilson PM, et al. Social prescribing: less rhetoric and more reality. A systematic review of the evidence. BMJ Open 2017; 7: e013384 What is this? The COVID-19 pandemic is placing a strain on health systems and healthcare workers. Existing research on social prescribing, which links patients in primary care to sources of support within the community, may provide information to ease this. In this systematic review, the authors searched for research evaluating any form of social prescribing programmes that had been conducted in the UK. They restricted the search to publications in English between 2000 and January 2016 and did the searches in February 2016. They included 1 randomised trial, 1 non-randomised trial, two qualitative studies, 4 uncontrolled before-and-after studies and 8 descriptive reports. What was found: Patient experience reports were generally positive about social prescribing in the UK, but the effects are not quantifiable. Although there may be a reduction in primary care and secondary care contacts, the extent of this, and the costs and health effects of social prescribing are uncertain.
url	https://www.evidenceaid.org/social-prescribing-for-primary-care-in-the-uk-costs-and-health-benefits-are-uncertain/ https://hdl.handle.net/20.500.12663/1212
work_keys_str_mv	AT allenclaire socialprescribingforprimarycareintheukcostsandhealthbenefitsareuncertain
_version_	1737882700709101568

Social prescribing for primary care in the UK: costs and health benefits are uncertain

Ejemplares similares